About DMSCAREPHARMA

DMSCAREPHARMA is a professional Chinese pharmaceutical manufacturer and exporter.
We specialize in R&D, GMP production and global supply of APIs, finished dosage forms and healthcare products.
Our main products cover Insulin, GLP-1 injection, antibiotics, eye drops, solid oral formulations and pharmaceutical raw materials. All goods meet USP and BP standards with complete certification and registration documents for worldwide markets.
dmscarepharma 005 1

Factory & Qualifications

We owns standardized GMP production workshops, independent R&D laboratory and complete quality inspection center.

All products strictly follow USP, EP, BP and CP standards, with strict raw material incoming inspection, production process monitoring and finished product full testing.

We can provide complete COA, HPLC, GC, DMF, dossier and registration supporting documents to meet the market access requirements of different countries.

Our Concept

We always adhere to the principle of Quality First, Credit Supreme, Customer Oriented. Stable quality, competitive factory price, professional document support and considerate after-sales service are our permanent advantages.

Our Mission

  • To achieve highest end-consumer satisfaction by providing quality products at affordable prices.
  • To provide new solutions for the age-old and new disorders and diseases by comprehensive Research and Development work.
  • To remain up to date with the latest knowledge and technology in the pharmaceutical industry.
  • And above all, our highest goal is to strengthen the health of the country and the entire world by our range of products and services.

    Equipment

    Manufacturing capability

    Manufacturing is organised by dosage form rather than by product, so the same equipment train, cleaning validation and in-process control logic apply across a whole presentation family. The portfolio covers nine presentations: injections and infusions, tablets, capsules, ophthalmic preparations, suppositories, oral suspensions, syrups, granules and medical consumables.

    • Sterile and parenteral — aseptic filling for ampoules, vials and IV fluids, with sterility, bacterial endotoxin and container-closure testing as part of release.
    • Solid dosage — granulation, compression and coating lines with dissolution and uniformity of dosage units in the release specification.
    • Liquids — suspension and solution manufacture with fill-volume control and microbial limits appropriate to the preservative system.
    • Non-sterile topical and rectal — ophthalmic preparations and suppositories, where container and preservative decisions are part of the specification.

    Quality system and release testing

    Production runs in standardised GMP workshops with an independent R&D laboratory and a complete quality-inspection centre. Materials are manufactured and tested against USP, EP, BP and CP monographs. The laboratory covers HPLC and GC for assay and related substances, dissolution testing, uniformity of dosage units, water content, pH and microbiological limits; sterile products add sterility and bacterial endotoxin testing.

    Every batch is released on a certificate of analysis naming the method used. We publish the licence basis on which we manufacture — DML Jin20160068 for medicines and Jin20160069 for paracetamol API — because a registration file has to show the authority which site and which licence the product comes from.

    Registration and dossier support

    • CTD dossier modules 1–5 in editable and PDF form
    • Site Master File and GMP certificate for the manufacturing workshops
    • Stability data and shelf-life justification for the marketed pack
    • Method validation reports and the specification agreed with your quality team
    • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file
    • Support for sample quantities, bioequivalence study material and pre-shipment document review

    Markets and export experience

    We export to buyers in the Middle East, Africa, Southeast Asia, Latin America and the CIS. Consignments ship with commercial invoice, packing list, certificate of origin, GMP certificate, certificate of analysis and, where required, the free-sale certificate from the country of manufacture. Artwork can be produced in English, Arabic, French, Russian and Spanish, and in your own brand where the destination labelling rules allow it.

    How we choose what to manufacture

    The portfolio is deliberately weighted towards medicines that public programmes procure, because those are the products with a durable, specification-driven demand. The WHO Model List is the reference point: it specifies the presentation as well as the molecule, so a supplier who cannot confirm the exact strength, dosage form and pack is not yet answering a tender. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)

    Questions buyers ask

    Which licences cover your manufacture?

    Drug manufacturing licences DML Jin20160068 (medicines) and DML Jin20160069 (paracetamol API). The licence, the manufacturing site and the GMP certificate are part of the dossier package and are provided on request.

    Can we audit the manufacturing site?

    Yes. Audit scheduling and the documentation pack to review beforehand — quality manual, validation summaries, batch records for comparable products and deviation history — are arranged through the contact page.

    Do you supply products outside the WHO Model List?

    Yes. The Model List governs programme procurement; it does not restrict what may be manufactured. Products outside the list are quoted on the same specification and documentation discipline, provided the destination market accepts the route.

    Where to look next

    Product catalogue · Therapeutic ranges · Nutrition & supplements · Contact & quotation

    Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.